Another Johnson & Johnson drug plant gets flagged

By Parija Kavilanz, senior writer


NEW YORK (CNNMoney.com) -- Johnson & Johnson, already under fire from the government over deplorable conditions at a Pennsylvania plant that makes children's pain and cold drugs, is now being cited for problems at another one of its drugmaking plants in the state.

A plant located in Lancaster, Pa., was recently inspected by the Food and Drug Administration and failed to receive a clean bill of health, according to the company.

The Lancaster facility received what is called a "Form 483." A Form 483 is issued after an FDA inspection yields unsatisfactory results for compliance with regulations or a violation of good manufacturing practices.

The FDA regional office in Philadelphia did not return calls seeking details about the observations made in the report. However, Johnson & Johnson confirmed that the company has received it.

The facility is a operated by Johnson & Johnson-Merck Consumer Pharmaceuticals, a joint venture of J&J (JNJ, Fortune 500) and drugmaker Merck (MRK, Fortune 500) formed to develop and market over-the-counter drugs derived from Merck's prescription medicines. The unit makes non-prescription products such as heartburn relievers Mylanta and Pepcid and multi-symptom relief drug Imodium.

"JJ/MCP takes the issues raised by the agency seriously and is fully committed to addressing their concerns as rapidly as possible," the companies said in a statement. "We will provide a detailed response to the FDA and work diligently to address all observations."

Experts in FDA regulatory compliance said companies tend to take Form 483 reports seriously. If a company does not adequately address the deficiencies cited in a report, the FDA can issue another one or escalate its response to a warning letter. Failure to correct violations can result in fines or even tougher measures by the FDA.

For example, a plant in Fort Washington, Pa., run by J&J's drug making unit McNeil Consumer Healthcare, received Form 483 reports prior to its shutdown in early May, the same month that McNeil recalled about 135 million bottles of children's and infant's Motrin, Tylenol and other drugs made at the plant. (See correction, below)

McNeil has begun an overhaul of that facility to bring it into FDA compliance.

Also, the FDA issued a warning letter earlier in January to McNeil citing manufacturing violations at its plant in Puerto Rico, after McNeil issued a recall of several over-the-counter drugs made at the plant including Tylenol, Motrin and Benadryl following complaints of an "unusual moldy, musty or mildew-like" odor.

Late Thursday, McNeil announced a mass layoff of hundreds of workers at the Fort Washington plant, where all production has been suspended after the FDA cited multiple safety and quality violations there.

Given the intense scrutiny on Johnson & Johnson and its McNeil division, one expert said a new Form 483 issued on another of the company's factories doesn't bode well.

"It shows that there is a systemic issue at the company and management has to do a better job in bringing the facilities into compliance with FDA regulations," said Bill Kurani, founder of Antrix Inc., a regulatory affairs & quality assurance consulting firm.

Correction: CNNMoney incorrectly reported that the FDA issued a warning letter to McNeil for its Fort Washington, PA. plant. The warning letter was sent to its plant in Puerto Rico. To top of page

Frontline troops push for solar energy
The U.S. Marines are testing renewable energy technologies like solar to reduce costs and casualties associated with fossil fuels. Play
25 Best Places to find rich singles
Looking for Mr. or Ms. Moneybags? Hunt down the perfect mate in these wealthy cities, which are brimming with unattached professionals. More
Fun festivals: Twins to mustard to pirates!
You'll see double in Twinsburg, Ohio, and Ketchup lovers should beware in Middleton, WI. Here's some of the best and strangest town festivals. Play
Index Last Change % Change
Dow 16,408.54 -16.31 -0.10%
Nasdaq 4,095.52 9.29 0.23%
S&P 500 1,864.85 2.54 0.14%
Treasuries 2.72 0.08 3.19%
Data as of 12:48pm ET
Company Price Change % Change
Bank of America Corp... 16.15 0.00 0.00%
Facebook Inc 58.94 0.00 0.00%
General Electric Co 26.56 0.00 0.00%
Cisco Systems Inc 23.21 0.00 0.00%
Micron Technology In... 23.91 0.00 0.00%
Data as of Apr 17
Sponsors

Sections

Spencer has been a supporting member of the "Good Morning America" cast for the past three years. More

Obamacare sign ups hit 8 million, though final enrollment remains to be seen. More

Office for iPad move is a symbolic victory for Nadella's Microsoft, but the company is still weighed down by many of the same old issues. More

Schwinn, Trek and Cannondale are all iconic American bicycle brands. But none of them are made in the United States. More

As Detroit moves closer to reaching a bankruptcy deal, retired civilian workers are poised to be left worse off than firemen and police officers. More

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.